Author

Manu Vanaerschot

Chan Zuckerberg Biohub San FranciscoORCID 0000-0002-9141-2347Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Genomics· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Approach:statistical model· 1 Organism:virus· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

Alex Espinosa· 1 shared Amanda K. LukensiD· 1 shared Amy L. KistleriD· 1 shared Andreas S. PuschnikiD· 1 shared Angela M. DetweileriD· 1 shared Annie N. CowelliD· 1 shared Christin ReimeriD· 1 shared Christine H. TengiD· 1 shared

Activity by Year

2017-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Alex Espinosa

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Identification of a polymorphism in the N gene of SARS-CoV-2 that adversely impacts detection by a widely-used RT-PCR assay

Manu Vanaerschot, Sabrina A Mann, James T. Webber, Jack Kamm, Sidney M. Bell, John Bell, Si Noon Hong, Minh Phuong Nguyen, Lienna Y. Chan, Karan D. Bhatt, Michelle Tan, Angela M. Detweiler, Alex Espinosa, Wesley C. H. Wu, Joshua Batson, , Emily D. Crawford

The paper identifies a SARS-CoV-2 N gene polymorphism that reduces RT-PCR assay sensitivity and emphasizes the need for multi-target testing.

bioRxiv · Aug 25, 2020 · PreprintMolecular Biology

Mapping The Malaria Parasite Drug-Able Genome Using In Vitro Evolution And Chemogenomics

Annie N. Cowell, Eva S. Istvan, Amanda K. Lukens, Marı́a G. Gómez-Lorenzo, Manu Vanaerschot, Tomoyo Sakata, Erika L. Flannery, Pamela Magistrado-Coxen, Matthew Abraham, Gregory LaMonte, Roy M. Williams, Virginia Franco, María Linares, Ignacio Arriaga, Selina E. R. Bopp, , Elizabeth A. Winzeler

Whole genome sequencing reveals how Plasmodium falciparum evolves resistance to diverse compounds and identifies new antimalarial drug targets.

bioRxiv · May 22, 2017 · PreprintGenomics